From Molecule to Manufacturing™
Independent advisory for specialty chemicals, fluorochemicals, CDMO scale-up, technology commercialization and capital projects.
14+ years experience across:
Supporting investors, technology owners and manufacturers in projects ranging from $17M to $385M.
Clarity before capital commitment
High-stakes chemical investments demand independent technical judgement. These are the questions we answer.
Technology Evaluation
“We found a technology. Does it actually work at commercial scale?”
Project Development
“We want to build a chemical plant. Is the investment viable?”
Scale-Up
“We have a lab process. How do we manufacture it safely and profitably?”
Investment Decisions
“We need independent technical due diligence before investing.”
Deep, practical sector expertise
Fluorochemicals
Direct fluorination, HF handling, specialty fluorine chemistry.
Chlor-Alkali
Caustic soda, chlorine, hydrochloric acid and derivatives.
Nitric Acid & Fertilizers
Nitric acid, ammonium nitrate, emissions reduction and sustainability.
Specialty Chemicals
Process development, commercialization and debottlenecking.
CDMO
Technology transfer and manufacturing scale-up.
Carbon & Sustainability
N₂O abatement, carbon projects and ESG integration.
The heart of what we do
Senior-led advisory structured to give investors, boards and operations teams the clarity to move forward.
Project Development Advisory
For investors and chemical manufacturers evaluating new manufacturing opportunities.
Deliverables
- Feasibility studies
- Technology selection
- Capex estimates
- Vendor assessment
- Project risk analysis
Technology Due Diligence
Independent review of process technologies before acquisition, licensing or investment.
Deliverables
- Technical assessment
- Scale-up feasibility
- Manufacturing readiness
- Commercial risk review
CDMO & Scale-Up Advisory
Supporting transition from laboratory process to commercial manufacturing.
Deliverables
- Technology transfer
- Process scale-up
- Plant fit assessment
- CDMO selection
Technology Commercialization
Helping technology owners identify investors, manufacturers and licensing partners.
Deliverables
- Market positioning
- Partner identification
- Technical representation
- Licensing support
A different kind of advisor
Most consultants bring one perspective. We bring the full lifecycle — design, operations and scale-up — from the owner's chair.
| Typical Consultant | Our Advisory |
|---|---|
| Design experience only | Design + Operations + Scale-up |
| EPC perspective | Owner's perspective |
| Limited commercial understanding | Techno-commercial decision making |
| Generic chemicals | Specialty chemicals expertise |
| Theoretical fluorine knowledge | Practical fluorine experience |
| Focus on reports | Focus on investment decisions |
Track record on landmark programs
Nitric Acid Program
Technology and licensor selection for integrated nitric acid and ammonium nitrate complex.
CDMO Program
Commercialization and scale-up of fluorochemical intermediate manufacturing.
Direct Fluorination
Scale-up and commissioning of advanced fluorination capability.
Chlor-Alkali
Plant commissioning and production leadership.
Flexible ways to work together
Technical Due Diligence
Fixed Fee
Strategic Advisory
Monthly Retainer
Owner's Representative
Project Basis
Technology Commercialization
Retainer + Success Fee
Saswat Satpathy
Capital Projects & Specialty Chemicals Advisor
14 years of experience across specialty chemicals, fluorochemicals, nitric acid, chlor-alkali and agrochemical manufacturing.
Led or supported projects with combined value exceeding $600M.
Specialized in technology commercialization, scale-up, project development and technical due diligence.
Insight for chemical decision-makers
Download our perspective on the technical and commercial risks that decide chemical project outcomes.
Why Specialty Chemical Projects Fail
How to Evaluate Chemical Technologies
Scale-Up Risks in Fluorochemicals
Choosing a Nitric Acid Licensor
CDMO vs Captive Manufacturing
Planning a Chemical Project?
Whether evaluating a new technology, scaling a process or investing in a manufacturing asset, independent technical advice can significantly reduce execution risk.
Book a Confidential Consultation